Cargando…

Do policy-makers find commissioned rapid reviews useful?

BACKGROUND: Rapid reviews are increasingly used by policy agencies to access relevant research in short timeframes. Despite the growing number of programmes, little is known about how rapid reviews are used by health policy agencies. This study examined whether and how rapid reviews commissioned usi...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Gabriel, Redman, Sally, Rudge, Sian, Haynes, Abby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828139/
https://www.ncbi.nlm.nih.gov/pubmed/29482643
http://dx.doi.org/10.1186/s12961-018-0293-1
_version_ 1783302583186620416
author Moore, Gabriel
Redman, Sally
Rudge, Sian
Haynes, Abby
author_facet Moore, Gabriel
Redman, Sally
Rudge, Sian
Haynes, Abby
author_sort Moore, Gabriel
collection PubMed
description BACKGROUND: Rapid reviews are increasingly used by policy agencies to access relevant research in short timeframes. Despite the growing number of programmes, little is known about how rapid reviews are used by health policy agencies. This study examined whether and how rapid reviews commissioned using a knowledge brokering programme were used by Australian policy-makers. METHODS: This study used interview data to examine the use of 139 rapid reviews by health policy agencies that were commissioned between 2006 and 2015. Transcripts were coded to identify how rapid reviews were used, the type of policy processes in which they were used, what evidence of use was provided and what reasons were given when rapid reviews were not used. Fisher’s exact test was used to assess variation between types of agencies. RESULTS: Overall, 89% of commissioned rapid reviews were used by the commissioning agencies and 338 separate instances of use were identified, namely, on average, three uses per review. Policy-makers used reviews primarily to determine the details of a policy or programme, identify priorities for future action or investment, negotiate interjurisdictional decisions, evaluate alternative solutions for a policy problem, and communicate information to stakeholders. Some variation in use was observed across agencies. Reasons for non-use were related to changes in organisational structures, resources or key personnel in the commissioning agencies, or changes in the broader political environment. CONCLUSIONS: This study found that almost all rapid reviews had been used by the agencies who commissioned them, primarily in policy and programme development, agenda-setting, and to communicate information to stakeholders. Reviews were used mostly in instrumental and conceptual ways and there was little evidence of symbolic use. Variations in use were identified across agencies. The findings suggest that commissioned rapid reviews are an effective means of providing timely relevant research for use in policy processes and that review findings may be applied in a variety of ways. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12961-018-0293-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5828139
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58281392018-02-28 Do policy-makers find commissioned rapid reviews useful? Moore, Gabriel Redman, Sally Rudge, Sian Haynes, Abby Health Res Policy Syst Research BACKGROUND: Rapid reviews are increasingly used by policy agencies to access relevant research in short timeframes. Despite the growing number of programmes, little is known about how rapid reviews are used by health policy agencies. This study examined whether and how rapid reviews commissioned using a knowledge brokering programme were used by Australian policy-makers. METHODS: This study used interview data to examine the use of 139 rapid reviews by health policy agencies that were commissioned between 2006 and 2015. Transcripts were coded to identify how rapid reviews were used, the type of policy processes in which they were used, what evidence of use was provided and what reasons were given when rapid reviews were not used. Fisher’s exact test was used to assess variation between types of agencies. RESULTS: Overall, 89% of commissioned rapid reviews were used by the commissioning agencies and 338 separate instances of use were identified, namely, on average, three uses per review. Policy-makers used reviews primarily to determine the details of a policy or programme, identify priorities for future action or investment, negotiate interjurisdictional decisions, evaluate alternative solutions for a policy problem, and communicate information to stakeholders. Some variation in use was observed across agencies. Reasons for non-use were related to changes in organisational structures, resources or key personnel in the commissioning agencies, or changes in the broader political environment. CONCLUSIONS: This study found that almost all rapid reviews had been used by the agencies who commissioned them, primarily in policy and programme development, agenda-setting, and to communicate information to stakeholders. Reviews were used mostly in instrumental and conceptual ways and there was little evidence of symbolic use. Variations in use were identified across agencies. The findings suggest that commissioned rapid reviews are an effective means of providing timely relevant research for use in policy processes and that review findings may be applied in a variety of ways. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12961-018-0293-1) contains supplementary material, which is available to authorized users. BioMed Central 2018-02-26 /pmc/articles/PMC5828139/ /pubmed/29482643 http://dx.doi.org/10.1186/s12961-018-0293-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Moore, Gabriel
Redman, Sally
Rudge, Sian
Haynes, Abby
Do policy-makers find commissioned rapid reviews useful?
title Do policy-makers find commissioned rapid reviews useful?
title_full Do policy-makers find commissioned rapid reviews useful?
title_fullStr Do policy-makers find commissioned rapid reviews useful?
title_full_unstemmed Do policy-makers find commissioned rapid reviews useful?
title_short Do policy-makers find commissioned rapid reviews useful?
title_sort do policy-makers find commissioned rapid reviews useful?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828139/
https://www.ncbi.nlm.nih.gov/pubmed/29482643
http://dx.doi.org/10.1186/s12961-018-0293-1
work_keys_str_mv AT mooregabriel dopolicymakersfindcommissionedrapidreviewsuseful
AT redmansally dopolicymakersfindcommissionedrapidreviewsuseful
AT rudgesian dopolicymakersfindcommissionedrapidreviewsuseful
AT haynesabby dopolicymakersfindcommissionedrapidreviewsuseful